Published in J Virol on September 01, 1994
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol (2003) 4.42
Interleukin-12 inhibits hepatitis B virus replication in transgenic mice. J Virol (1997) 2.50
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc Natl Acad Sci U S A (2004) 1.96
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother (1997) 1.94
Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol (1997) 1.87
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection. World J Gastroenterol (2007) 1.77
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol (2000) 1.73
The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. J Virol (1995) 1.72
Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest (1997) 1.62
Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc Natl Acad Sci U S A (2003) 1.58
Tumor necrosis factor alpha inhibition of hepatitis B virus replication involves disruption of capsid Integrity through activation of NF-kappaB. J Virol (2003) 1.55
Molecular biology of hepatitis B virus infection. Virology (2015) 1.47
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A (2007) 1.46
Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother (1998) 1.45
Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol (1996) 1.45
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol (1994) 1.37
Targeting Hepatitis B Virus With CRISPR/Cas9. Mol Ther Nucleic Acids (2014) 1.33
Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci U S A (2005) 1.29
Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope. J Virol (1997) 1.27
Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. J Virol (2007) 1.27
Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc Natl Acad Sci U S A (2003) 1.22
The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc Natl Acad Sci U S A (2007) 1.19
Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol (2010) 1.18
Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proc Natl Acad Sci U S A (2005) 1.17
The level of viral antigen presented by hepatocytes influences CD8 T-cell function. J Virol (2007) 1.16
T-Cell response to woodchuck hepatitis virus (WHV) antigens during acute self-limited WHV infection and convalescence and after viral challenge. J Virol (1998) 1.10
Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol (2002) 1.05
Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice. J Virol (1997) 1.04
Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections. J Virol (2000) 0.99
Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics. Antiviral Res (2015) 0.94
Immune selection during chronic hepadnavirus infection. Hepatol Int (2007) 0.91
The liver of woodchucks chronically infected with the woodchuck hepatitis virus contains foci of virus core antigen-negative hepatocytes with both altered and normal morphology. Virology (2006) 0.91
The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J Virol (2008) 0.90
Rapid production of neutralizing antibody leads to transient hepadnavirus infection. J Virol (2004) 0.88
n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes. J Virol (1996) 0.88
Molecular biology of the hepatitis B virus for clinicians. J Clin Exp Hepatol (2012) 0.87
Pharmacodynamics of (-)-beta-2',3'-dideoxy-3'-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans. Antimicrob Agents Chemother (1998) 0.85
Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection. J Virol (2008) 0.84
Natural history of chronic hepatitis B virus infection. Med Microbiol Immunol (2014) 0.84
STING agonists induce an innate antiviral immune response against hepatitis B virus. Antimicrob Agents Chemother (2014) 0.82
Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus. Antimicrob Agents Chemother (2001) 0.82
Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection. PLoS One (2015) 0.82
Role natural killer group 2D-ligand interactions in hepatitis B infection. World J Hepatol (2015) 0.80
Animal models and the molecular biology of hepadnavirus infection. Cold Spring Harb Perspect Med (2015) 0.79
Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription. PLoS One (2013) 0.79
Transcriptome-Wide Analysis of Hepatitis B Virus-Mediated Changes to Normal Hepatocyte Gene Expression. PLoS Pathog (2016) 0.78
Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load. World J Gastroenterol (2009) 0.78
Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients. Comp Hepatol (2007) 0.78
Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck. Med Microbiol Immunol (2014) 0.76
Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res (2016) 0.75
Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci U S A (1979) 72.18
A simple, rapid, and sensitive DNA assay procedure. Anal Biochem (1980) 23.88
Apoptosis. Immunol Today (1993) 4.23
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A (1994) 3.34
Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell (1991) 3.31
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol (1988) 3.21
A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis (1987) 2.98
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Transmission of type B viral hepatitis to chimpanzees. J Infect Dis (1973) 2.51
Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice. J Virol (1992) 2.25
Core antigen and antibody in woodchucks after infection with woodchuck hepatitis virus. J Virol (1984) 1.97
Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet (1989) 1.95
Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways. J Virol (1994) 1.94
Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology (1988) 1.85
Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. J Virol (1993) 1.76
Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology (1989) 1.39
Cell lineages in hepatic development and the identification of progenitor cells in normal and injured liver. Proc Soc Exp Biol Med (1993) 1.38
Ground squirrel hepatitis virus infection. Hepatology (1983) 1.36
In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology (1989) 1.34
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
Models for hepatic progenitor cell activation. Proc Soc Exp Biol Med (1993) 1.19
Hepatic stem cell compartment: activation and lineage commitment. Proc Soc Exp Biol Med (1993) 1.16
Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. Gastroenterology (1978) 1.13
Laboratory assessment of hepatic injury in the woodchuck (Marmota monax). Lab Anim Sci (1985) 1.09
Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol (1989) 1.08
Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks. Virology (1988) 1.06
Cellular and molecular mechanisms of hepatocarcinogenesis associated with hepadnavirus infection. Curr Top Microbiol Immunol (1991) 1.06
Woodchuck hepatitis virus: experimental infection and natural occurrence. Hepatology (1984) 1.03
Immunopathologic aspects of woodchuck hepatitis. Am J Pathol (1984) 0.98
A technique for liver biopsy performed in Pekin ducks using anesthesia with Telazol. Lab Anim Sci (1991) 0.95
Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell (1982) 16.71
Hepatitis B virus biology. Microbiol Mol Biol Rev (2000) 7.58
Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol (1980) 6.56
Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA. Proc Natl Acad Sci U S A (1982) 4.69
Genetic recombinants and heterozygotes derived from endogenous and exogenous avian RNA tumor viruses. Virology (1973) 4.56
Analysis of integrated avian RNA tumor virus DNA in transformed chicken, duck and quail fibroblasts. J Virol (1979) 4.34
Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol (1990) 3.53
Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol (1986) 3.46
Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J Virol (1983) 3.35
Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol (1994) 3.34
Synthesis and processing of polymerase proteins of wild-type and mutant avian retroviruses. J Virol (1980) 2.92
Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J Virol (1987) 2.89
Experimental transmission of duck hepatitis B virus. Virology (1983) 2.77
In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology (1990) 2.76
Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol (1984) 2.72
Necropsy or autopsy? It's all about communication! Vet Pathol (2011) 2.59
Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol (1992) 2.54
Characterization of two conditional early mutants of Rous sarcoma virus. Virology (1973) 2.42
Retroid virus genome replication. Adv Virus Res (1987) 2.23
Some factors affecting cyclopropane acid formation in Escherichia coli. Biochem J (1965) 2.21
Viral nucleic acid synthesis and antigen accumulation in pancreas and kidney of Pekin ducks infected with duck hepatitis B virus. Proc Natl Acad Sci U S A (1983) 2.12
An extracellular lipopolysaccharide-phospholipid-protein complex produced by Escherichia coli grown under lysine-limiting conditions. Biochem J (1967) 2.10
Mapping oligonucleotides of Rous sarcoma virus RNA that segregate with polymerase and group-specific antigen markers in recombinants. Proc Natl Acad Sci U S A (1976) 2.04
Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol (2001) 1.98
Vision screening for frail older people: a randomised trial. Br J Ophthalmol (2008) 1.93
DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile. Nature (1974) 1.90
Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus. J Virol (1997) 1.87
Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus. Virology (1988) 1.85
Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis. Virology (1992) 1.77
A clinical audit of patients on an orthopaedic waiting list for greater than two years. N Z Med J (1992) 1.76
Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections. J Virol (2000) 1.73
A mutant of Rous sarcoma virus with a conditional defect in the determinant(s) of viral host range. Virology (1977) 1.72
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J Clin Oncol (1999) 1.61
Fourteen temperature-sensitive replication mutants of Rous sarcoma virus. Virology (1979) 1.61
Identification of an avian oncovirus polyprotein in uninfected chick cells. Cell (1978) 1.60
Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology (1990) 1.56
Lamivudine therapy of WHV-infected woodchucks. Virology (1998) 1.52
Tandem duplication of the proviral DNA in an avian sarcoma virus-transformed quail clone. J Virol (1981) 1.52
Expression of the Major Viral Glycoprotein of Avian Tumor Virus in Cells of chf(+) Chicken Embryos. J Virol (1975) 1.48
Intestinal structure and function after small bowel by-pass in the rat. Clin Sci (1972) 1.47
Alpha-streptococcal septicemia in leukemic children treated with continuous or large dosage intermittent cytosine arabinoside. Pediatr Infect Dis J (1989) 1.45
Covalently closed circular viral DNA formed from two types of linear DNA in woodchuck hepatitis virus-infected liver. J Virol (1996) 1.45
Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles. J Virol (1995) 1.41
Sensitivity and specificity of the neonatal brain-stem auditory evoked potential for hearing and language deficits in survivors of extracorporeal membrane oxygenation. J Pediatr (1997) 1.40
Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks. J Virol (1994) 1.37
In vitro infection of woodchuck hepatocytes with woodchuck hepatitis virus and ground squirrel hepatitis virus. Virology (1989) 1.34
Determination of the defective function in two mutants of Rous sarcoma virus. Virology (1974) 1.33
Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. Hepatology (1994) 1.29
Major differences between WHV and HBV in the regulation of transcription. Virology (1997) 1.27
Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust N Z J Public Health (1998) 1.26
High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outcomes. Pediatrics (1996) 1.26
Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther (2001) 1.21
Cytoplasmic (but not nuclear) hepatitis B virus (HBV) core antigen reflects HBV DNA synthesis at the level of the infected hepatocyte. Intervirology (1985) 1.21
Fatty acid synthesis in Escherichia coli. Biochem J (1967) 1.20
Viral DNA synthesis. Curr Top Microbiol Immunol (1991) 1.19
Emergence of drug-resistant populations of woodchuck hepatitis virus in woodchucks treated with the antiviral nucleoside lamivudine. Antimicrob Agents Chemother (1999) 1.16
Individual cells in tissues of DHBV-infected ducks express antigens crossreactive with those on virus surface antigen particles and immature viral cores. Virology (1984) 1.16
Immunoblot analysis demonstrates that the large and small forms of hepatitis delta virus antigen have different C-terminal amino acid sequences. J Gen Virol (1992) 1.16
Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology (1987) 1.14
Proceedings: A study of the effectiveness, toxicity, and bile salt kinetics of chenodeoxycholic acid in the treatment of human gallstones. Gut (1973) 1.14
TeleBAT: mobile telemedicine for the Brain Attack Team. J Stroke Cerebrovasc Dis (2007) 1.13
Can GP input into discharge planning result in better outcomes for the frail aged: results from a randomized controlled trial. Fam Pract (1999) 1.12
The effects of temperature on the composition and physical properties of the lipids of Pseudomonas fluorescens. Biochem J (1971) 1.11
Initial experience with transvaginal incisional hernia repair. Hernia (2009) 1.09
Synthesis and integration of avian sarcoma virus DNA. Cold Spring Harb Symp Quant Biol (1980) 1.09
The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver. J Virol (1994) 1.08
Avian sarcoma virus-transformed quail clones defective in the production of focus-forming virus. J Virol (1979) 1.07
Correlation between liver histology and markers of hepatitis B virus replication in infected patients: a study by in situ hybridization. Hepatology (1984) 1.07
Stable expression of hepatitis delta virus antigen in a eukaryotic cell line. J Gen Virol (1990) 1.07
Patterns of single- and double-stranded hepatitis B virus DNA and viral antigen accumulation in infected liver cells. J Gen Virol (1983) 1.06
Central nervous system lymphosarcoma in the dog. J Am Vet Med Assoc (1984) 1.06
A replication defective mutant of Rous sarcoma virus which fails to make a functional reverse transcriptase. Virology (1975) 1.05
Identification of factor-binding sites in the duck hepatitis B virus enhancer and in vivo effects of enhancer mutations. J Virol (1994) 1.04
Inhibition of duck hepatitis B virus replication by hypericin. Antiviral Res (1993) 1.02
Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev (1998) 1.01
Chenodeoxycholic acid therapy for gallstones: effectiveness, toxicity and influence on bile acid metabolism. Q J Med (1975) 1.01